NovoCure: 2Q Earnings Snapshot
SAINT HELIER, Jersey (AP) _ NovoCure Ltd. (NVCR) on Thursday reported a loss of $1.3 million in its second quarter.
On a per-share basis, the Saint Helier, Jersey-based company said it had a loss of 1 cent.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 7 cents per share.
The oncology drug developer posted revenue of $86.7 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $81.5 million.
NovoCure shares have more than doubled since the beginning of the year. The stock has increased 96% in the last 12 months.